We are advancing AI to power the future of medicine.

At Unlearn, our purpose is to advance artificial intelligence (AI) to eliminate trial and error in medicine. We are innovating advanced machine learning methods to leverage generative AI in forecasting patient outcomes, starting with the domain of clinical trials. We produce AI-generated digital twins of individual trial participants, enabling smaller and more efficient clinical trials to bring effective medicines to patients sooner.

Our innovative work in AI today will reinvent how AI is applied in medicine tomorrow — and we have a top secret plan for how to get there. We won’t be able to achieve this mission just by applying technologies created by others; the future must be invented.

Unlearn is a technology company, not a biotech company. We use computers, not pipettes. We make and use software, we don’t discover or make drugs. We believe that AI will define the future of medicine, and we aren’t deterred by naysayers or skeptics. 

We come from a variety of backgrounds ranging from machine learning to marketing—but regardless of where we come from, Unlearners share some common traits:

• Unlearners are ambitious; we aren’t intimidated by big, challenging goals. 

• Unlearners are disciplined experimenters; we break down our big goals into smaller chunks and meet as often as necessary to track our velocity and iterate quickly. 

• Unlearners are gritty; we never give up, setbacks just make us try harder.

• Unlearners are receptive to new ideas; in fact, we hate being stuck with the status quo

• Unlearners are storytellers; sharing information with each other and with the world is super important, too important to be boring. And, last but not least,

• Unlearners are team-oriented; we put the mission first, the company second, the team third, and individuals last.

Headquartered in San Francisco, with an additional office in Boston, Unlearn was founded in 2017 by a team of world-class machine learning scientists. We have raised venture capital from top tier investors such as Altimeter, Insight Partners, Radical Ventures, 8VC, DCVC, and DCVC Bio, and recently completed our $50 million Series C in January 2024.

If our purpose and culture resonate with you, we invite you to apply.

The Role 

Unlearn is looking for an experienced business development professional who is passionate about driving change in the pharmaceutical industry by selling AI-driven partnerships to clinical development teams.

Reporting to the Head of Business Development, the ideal candidate will be an expert at selling to senior clinical stakeholders in the pharmaceutical industry, such as Chief Medical Officer/Chief Scientific Officer/VP Clinical Development/Medical Director. The ideal candidate will be an expert in building deep relationships with internal and external stakeholders, have superb public speaking and storytelling skills, and happily take on the challenge of achieving ambitious sales goals to drive company success. You will also be happy to embrace new approaches that are outside the status quo and be a top-performer in a fast-paced, start-up, iterative, environment. 

Key Responsibilities

• Build strong and trusting relationships with key stakeholders: (Chief Medical Officer/Chief Scientific Officer/VP Clinical Development/Executive Medical Director) in Unlearn’s target pharmaceutical customers.

• Use superb storytelling skills to pitch Unlearn’s AI-powered clinical trials to target accounts.

• Strategically evaluate partnership opportunities and push forward the opportunities that align with Unlearn’s commercial, technology, and scientific goals.

• Collaborate with transactional experts on the business development team to close deals with target accounts.

• Collaborate with the Commercial team to develop, and refine business development strategies and tactics that will help Unlearn close a greater number of deals more quickly.

• Professionally represent Unlearn at events and conferences to support Unlearn being recognized as the undisputed leader of AI in healthcare.

Key Requirements

• Expert at selling into roles such as, Chief Medical Officer/Chief Scientific Officer/VP Clinical Development/Executive Medical Director.

• Deep understanding of the clinical development, approval, and commercialization process, and how AI companies like Unlearn solve key bottlenecks in that process.

• Experience working in clinical affairs or clinical development roles in a major pharmaceutical company, where you successfully negotiated deals between internal and external key stakeholders is a plus.

• Demonstrated proficiency to understand and communicate scientific and technical solutions focused on the intersection of deep learning and clinical development.

• 5+ years of sell-side business development experience with a focus on long-term partnerships in the pharmaceutical industry.

• Advanced degree (MS, PhD) in a STEM discipline is preferred

Travel requirement: 25-50%

Benefits & Perks

• Generous equity participation

• 100% company-covered medical, dental, & vision insurance plans

• 401k plan with generous matching

• Flexible PTO plus company holidays

• Annual company-wide break December 24 through January 1

• Professional development budget to attend conferences or other events

• Commuter benefits plan

• Paid Parental Leave

Unlearn is an equal opportunity employer. 

At Unlearn, we are committed to building a diverse and inclusive workplace, because inclusion and diversity are essential to achieving our mission. If you’re excited about this role, and your past experience doesn’t align perfectly with every qualification in the job description, we encourage you to apply nevertheless.

Compensation Range: $180K - $250K